Nurse Practitioner, Family · Phoenix, AZ
NPI
1225444052
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
500 W Thomas Rd Ste 500
Phoenix, AZ, 85013
Phone (602) 406-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
138 services
Medicare patients, 2024
67
Average age 73
Drug cost, 2024
$3.9M
1,234 prescriptions
Company payments, 2025
$9,289
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebekah Edwards was code 99215 (office e&m - established), 86 times for 49 patients. In total Rebekah Edwards billed 138 services in 8 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 86 | 49 | $114.86 | $9,878 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 14 | $21.32 | $448 |
| 99205 Office E&M - New | Office | 17 | 17 | $141.71 | $2,409 |
By year: 2022 $12K for 114 services; 2023 $14K for 136 services; 2024 $14K for 138 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebekah Edwards prescribed most often to Medicare patients was Prednisone, with 129 prescriptions and refills. In total Rebekah Edwards wrote 1,234 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 129 | 196 | 48 | $687 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 106 | 192 | 21 | $121K |
| Montelukast Sodium Generic | 92 | 182 | 21 | $770 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 72 | 91 | 26 | $1,660 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 70 | 119 | 18 | $319 |
| Ofev Nintedanib Esylate | 68 | 68 | Under 11 | $904K |
| Mycophenolate Mofetil Generic | 66 | 112 | 16 | $5,419 |
| Azithromycin Generic | 59 | 95 | 16 | $628 |
| Zemaira Alpha-1-Proteinase Inhibitor | 36 | 36 | Under 11 | $356K |
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 35 | 35 | Under 11 | $943K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 25 | $200 |
| Breo Ellipta Fluticasone/Vilanterol | 29 | 29 | Under 11 | $11K |
| Pirfenidone Generic | 25 | 25 | Under 11 | $77K |
| Prolastin C Alpha-1-Proteinase Inhibitor | 22 | 22 | Under 11 | $270K |
| Itraconazole Generic | 20 | 30 | Under 11 | $2,215 |
Brand drugs: - claims; generic drugs: 729 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebekah Edwards $9,289 ($9,289 in general payments such as food, travel and fees) from 14 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $8,918.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $8,918 |
| Insmed, Inc. INSM | 3 | $57.74 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $51.08 |
| Pharmacosmos Therapeutics Inc. | 1 | $32.79 |
| Vifor Pharma, Inc. | 1 | $32.33 |
| Amgen Inc. AMGN | 2 | $30.49 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $29.43 |
| Grifols USA, LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $24.52 |
| Verona Pharma, Inc. VRNA | 1 | $20.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.